APA (7th ed.) Citation

AK, N., DB, T., D, P., VK, S., & G, S. (2025). A novel synthetic approach for the piperazynyl pyrimidine intermediate: Focus on the cost cutting of buspirone drug at commercial level. Drug development and industrial pharmacy, 51(4), 365. https://doi.org/10.1080/03639045.2025.2473505

Chicago Style (17th ed.) Citation

AK, Nayak, Tripathy DB, Pendharkar D, Sharma VK, and Sharma G. "A Novel Synthetic Approach for the Piperazynyl Pyrimidine Intermediate: Focus on the Cost Cutting of Buspirone Drug at Commercial Level." Drug Development and Industrial Pharmacy 51, no. 4 (2025): 365. https://doi.org/10.1080/03639045.2025.2473505.

MLA (9th ed.) Citation

AK, Nayak, et al. "A Novel Synthetic Approach for the Piperazynyl Pyrimidine Intermediate: Focus on the Cost Cutting of Buspirone Drug at Commercial Level." Drug Development and Industrial Pharmacy, vol. 51, no. 4, 2025, p. 365, https://doi.org/10.1080/03639045.2025.2473505.